BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 26274027)

  • 21. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
    Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
    Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
    Tanaka M; Kato K; Gomi K; Matsumoto M; Kudo H; Shinkai M; Ohama Y; Kigasawa H; Tanaka Y
    Am J Surg Pathol; 2009 Sep; 33(9):1416-20. PubMed ID: 19606011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
    Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
    Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.
    Schoolmeester JK; Dao LN; Sukov WR; Wang L; Park KJ; Murali R; Hameed MR; Soslow RA
    Am J Surg Pathol; 2015 Mar; 39(3):394-404. PubMed ID: 25517951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
    Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
    [No Abstract]   [Full Text] [Related]  

  • 26. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
    Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
    Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
    Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
    Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion.
    Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.
    Argani P; Zhang L; Reuter VE; Tickoo SK; Antonescu CR
    Am J Surg Pathol; 2017 May; 41(5):655-662. PubMed ID: 28296677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
    Wang XT; Xia QY; Zhou XJ; Rao Q
    Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors.
    Szumera-Cieækiewicz A; Kuczkiewicz-Siemion O; Seliga K; Grabowska-Kierył M; Tysarowski A; Wągrodzki M; Świtaj T; Prochorec-Sobieszek M; Rutkowski P
    Pol J Pathol; 2019; 70(4):317-322. PubMed ID: 32146802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.
    Kurisaki-Arakawa A; Saito T; Takahashi M; Mitani K; Fukumura Y; Nagashima Y; Argani P; Yao T
    Int J Clin Exp Pathol; 2013; 6(11):2585-90. PubMed ID: 24228124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.
    Ohe C; Kuroda N; Hes O; Michal M; Vanecek T; Grossmann P; Tanaka Y; Tanaka M; Inui H; Komai Y; Matsuda T; Uemura Y
    Med Mol Morphol; 2012 Dec; 45(4):234-7. PubMed ID: 23224603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature.
    Jing H; Wei H; Yuan H; Li Y; Li N; Mu D
    Diagn Pathol; 2018 Aug; 13(1):51. PubMed ID: 30103811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations.
    Wang XT; Xia QY; Ye SB; Wang X; Li R; Fang R; Shi SS; Zhang RS; Tan X; Chen JY; Sun K; Teng XD; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Mod Pathol; 2018 Sep; 31(9):1346-1360. PubMed ID: 29713041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations.
    Jimbo N; Nishigami T; Noguchi M; Iijima H; Hirota S; Tajiri T; Inoue T; Hirose T; Itoh T; Zen Y
    Hum Pathol; 2017 Mar; 61():41-48. PubMed ID: 27865795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.
    Xia QY; Wang Z; Chen N; Gan HL; Teng XD; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Mod Pathol; 2017 Mar; 30(3):416-426. PubMed ID: 27934879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
    Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.